ArticleMolecular cancer therapeutics2022

Targeting the mTOR Pathway in Hurthle Cell Carcinoma Results in Potent Antitumor Activity.

Yiyu Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.